![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 18249-18252, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From The Physiological Laboratory, University of Liverpool, Crown
Street, Liverpool L69 3BX, United Kingdom
Received for publication, March 20, 2002
Membrane fusion during exocytosis and throughout
the cell is believed to involve members of the SNARE (soluble
N-ethylmaleimide-sensitive fusion protein attachment
protein receptors) family of proteins. The assembly of these proteins
into a four-helix bundle may be part of the driving force for bilayer
fusion. Regulated exocytosis in neurons and related cell types is
specialized to be fast and Ca2+-dependent
suggesting the involvement of other regulatory proteins specific for
regulated exocytosis. Among these are the complexins, two closely
related proteins that bind only to the assembled SNARE complex. We have
investigated the function of complexin by analysis of single vesicle
release events in adrenal chromaffin cells using carbon fiber
amperometry. These cells express complexin II, and overexpression of
this protein modified the kinetics of vesicle release events so that
their time course was shortened. This effect depended on complexin
interaction with the SNARE complex as introduction of a mutation of
Arg-59, a residue that interacts with synaptobrevin in the SNARE
complex, abolished its effects. The data are consistent with a function
for complexin in stabilizing an intermediate of the SNARE complex to
allow kiss-and-run recycling of the exocytosed vesicle.
The SNARE1 (soluble
N-ethylmaleimide-sensitive fusion protein attachment protein
receptors) proteins associate to form a SNARE complex (1) that has a
crucial role in membrane fusion events throughout the secretory pathway
as the core of a highly conserved fusion machinery (2). The
SNARE proteins syntaxin, SNAP-25, and vesicle-associated membrane
protein (synaptobrevin), involved in regulated exocytosis in
neurons and neuroendocrine cells, have been studied in most detail (3,
4). From in vitro studies, the neuronal SNAREs are
sufficient for membrane fusion when reconstituted in liposomes (5), but
this occurs in a Ca2+-independent manner and with kinetics
that are many orders of magnitude slower than exocytosis at the synapse
suggesting an essential requirement for other proteins. A prime
candidate for a protein that influences membrane fusion during
regulated exocytosis is complexin (6, 7) as it binds specifically to
the assembled SNARE complex (6, 8, 9).
Regulated exocytosis differs significantly from other membrane fusion
events. First, it is dependent upon an intracellular signal such as an
elevated Ca2+ concentration for its initiation (10).
Second, in synapses it is specialized to be able to occur within tens
of microseconds of Ca2+ elevation (11) through the rapid
formation of a transient fusion pore (12). Third, rapid retrieval of
the fused membrane is essential to maintain the releasable vesicle pool
(13). It is likely that proteins in addition to SNAREs are crucially
important for the control and kinetics of fast, regulated exocytosis.
Numerous proteins have been discovered that interact with the neuronal
SNARE proteins, and some of these are not expressed in organisms such
as yeast that lack regulated exocytosis. It is likely that these
proteins either impose Ca2+ sensitivity on the fusion
machinery (e.g. synaptotagmin) or contribute to the fast
kinetics of membrane fusion or retrieval during synaptic vesicle
exocytosis. Complexin binds to the assembled SNARE complex competitively with Plasmids--
A plasmid encoding complexin II (6) was
provided by Harvey McMahon (Medical Research Council Laboratory of
Molecular Biology, Cambridge, UK). The coding region was amplified by
polymerase chain reaction and ligated into pcDNA3.1. Site-directed
mutagenesis was used to generate the R59H mutation using the
QuikChange system (Stratagene). The primers were: sense,
5'-CATGGAAGCGGAACATGAGAAGGTCCGG-3'; and antisense,
5'-CCGGACCTTCTCATGTTCCGCTTCCATG-3'.
Cell Culture and Transfection of Chromaffin
Cells--
Isolated bovine adrenal chromaffin cells (18) were plated
on non-tissue culture-treated 10-cm Petri dishes and left overnight at
37 °C. Non-attached cells were resuspended in growth medium at a
density of 1 × 107/ml. Plasmids (encoding EGFP and
complexins) were mixed and added at 2 µg/1 × 106
cells, and cells were electroporated using a Bio-Rad Gene Pulser II
(Bio-Rad). The cells were then rapidly diluted to 1 × 106/ml with fresh growth medium and added to 35-mm Petri
dishes, made up to a volume of 3 ml with fresh growth medium, and
maintained in culture for 3-5 days.
Immunofluorescence--
Transfections were performed as
described above, and cells were plated onto round glass coverslips
(13-mm diameter). After washing twice with PBS, cells were fixed in 4%
formaldehyde in PBS for a minimum of 30 min at room temperature. Cells
were then washed twice in PBS, incubated for 30 min in blocking buffer
(0.3% bovine serum albumin, 0.5% Triton X-100 in PBS), and incubated overnight at 4 °C with L668 rabbit polyclonal antibody against complexin II (provided by Dr. Harvey McMahon) at a 1:500 dilution. Cells were then washed three times, incubated for 1 h in
biotinylated anti-rabbit IgG (Amersham Biosciences) at a 1:100
dilution, washed three times, and finally incubated in
streptavidin-Texas Red (Amersham Biosciences) at a 1:50 dilution for 30 min. After being mounted onto slides, cells were viewed with
appropriate filters to visualize EGFP and immunofluorescence.
Western Blotting--
HeLa cells were trypsinized, plated at a
density of 1 × 107 on 35-mm plates, and cultured in
Dulbecco's modified Eagle's medium with 5% fetal bovine
serum. After 5 h, the cells were transfected with 1 µg of
plasmid (pcDNA3 or the plasmids encoding complexin II or complexin
II(R59H)) using 3 µl of FuGENE transfection reagent (Roche Molecular
Biochemicals). After an additional 72 h, the cells were lysed in
200 µl of SDS dissociation buffer. Chromaffin cells were plated onto
35-mm plates and lysed in 200 µl of SDS dissociation buffer after 3 days. Synaptosomes were provided by Gareth Evans (The Physiology
Laboratory, University of Liverpool, UK). Samples were separated by
SDS-PAGE, transferred to nitrocellulose, and probed with L668 rabbit
polyclonal antibody against complexin II (1:1000), and bands were
visualized using enhanced chemiluminescence (Amersham Biosciences).
Amperometric Recording--
Cells were washed twice with PBS,
incubated in bath buffer (139 mM potassium glutamate, 0.2 mM EGTA, 20 mM PIPES, 2 mM ATP, and
2 mM MgCl2, pH 6.5) and viewed using a Nikon
TE300 inverted microscope. Transfected cells were identified as those
expressing EGFP. A 5-µm-diameter carbon fiber electrode was
positioned in contact with a cell. For stimulation, a glass
micropipette filled with cell permeabilization/stimulation buffer (139 mM potassium glutamate, 20 mM PIPES, 5 mM EGTA, 2 mM ATP, 2 mM
MgCl2, 20 µM digitonin, and 10 µM free Ca2+, pH 6.5) was positioned on the
opposite side of the cell from the carbon fiber. An Eppendorf
Transjector was used to pressure eject the buffer onto the cell for a
20-s pulse. Amperometric responses were monitored with a VA-10
amplifier (NPI Electronic), collected at 4 kHz, and digitized with a
Digidata 1322A acquisition system. Data were subsequently analyzed
using an automated peak detection and analysis protocol with the
technical graphics program Origin (Microcal) (19). All the data are
shown as mean ± S.E., and statistical differences were assessed
using the non-parametric Mann Whitney test.
Complexin I is expressed mainly in neurons, but complexin II is
expressed more widely. We, therefore, examined whether complexin II is
expressed in adrenal chromaffin cells by immunoblotting with
anti-complexin II. A single band was detected in chromaffin cells,
whereas an additional smaller polypeptide due to cross-reaction with
complexin I (6) was also detected in rat brain synaptosomes (Fig.
1A) suggesting that chromaffin
cells express mainly complexin II. Complexin II was detected in both
membrane and soluble pools from chromaffin cells. For examination of
complexin II function in chromaffin cells, we aimed to overexpress
wild-type protein and a form with the R59H mutation. Arg-59 in
complexin makes crucial contacts with synaptobrevin in the SNARE
complex and is likely to be crucial for complexin binding to the
complex (17). In chromaffin cells, co-transfected to express EGFP,
expression of both complexin proteins above endogenous levels could be
demonstrated (Fig. 1B). The transfection efficiency for
chromaffin cells is too low to demonstrate expression by
immunoblotting. Analysis of expression levels was carried out using
HeLa cells, therefore, where similar expression levels of both
wild-type and mutant proteins could be demonstrated following
transfection (Fig. 1C).
The effect of overexpression of complexin II on the extent of
exocytosis and the characteristics and kinetics of single vesicle release events was examined using carbon fiber amperometry (20). In
each case data from transfected cells were directly compared with data
from control, untransfected cells in the same dishes and using the same
carbon fibers (28-38 cells for each condition). Complexin II
overexpression partially inhibited exocytosis and also reduced the
average charge released in each spike (Fig.
2) showing that less catecholamine was
released during each exocytotic event (a reduction in quantal size). To
determine whether these effects were due to interaction of complexin II
with the SNARE complex or some nonspecific effect we examined the
consequence of expressing the specific R59H mutant of complexin II. The
specificity of the complexin II effect on exocytosis was
demonstrated by the finding that complexin II(R59H) had no effect on
the extent of exocytosis or on quantal size in transfected cells (Fig.
3).
ACCELERATED PUBLICATION
Complexin Regulates the Closure of the Fusion Pore during
Regulated Vesicle Exocytosis*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-SNAP (6). Knockout of either one of the two
complexin isoforms, I and II, produces a mild (II) or moderate (I)
phenotype (14, 15). In contrast, the double complexin I/II knockout
mouse dies shortly after birth and shows a marked impairment of
Ca2+-evoked neurotransmission (15). The exact contribution
of complexin to SNARE complex assembly is controversial (9, 16), but
recent structural data suggest binding of a single complexin to each independent SNARE complex via association of the complexin C-terminal domain with residues from syntaxin and synaptobrevin (9, 17). Here we
have investigated the function of complexin by analysis of single
vesicle release events in adrenal chromaffin cells using amperometry
and demonstrated a novel effect of complexin II on release kinetics
that depends on its interaction with the SNARE complex. The data are
consistent with a function for complexin in controlling the closure of
the fusion pore to elicit rapid kiss-and-run recycling of the
exocytosed vesicle.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (32K):
[in a new window]
Fig. 1.
Expression and overexpression of complexin
II. A, samples of isolated bovine chromaffin cells and
rat brain synaptosomes were analyzed by SDS-polyacrylamide gel
electrophoresis and immunoblotting with anti-complexin II. A single
band corresponding to complexin II was detected in chromaffin cells
(even after prolonged exposure of the blot), whereas an additional
smaller band corresponding to complexin I was detected in synaptosomes.
B, overexpression of complexin II or complexin II(R59H) was
observed in EGFP-expressing chromaffin cells after transfection using
immunofluorescence with anti-complexin II at levels of antiserum that
gave only background staining of untransfected cells
(arrow). C, comparison of expression levels of
complexin II and complexin II(R59H) in transfected HeLa cells by
immunoblotting. CPXII, complexin II.

View larger version (13K):
[in a new window]
Fig. 2.
Amperometric recording of evoked exocytosis
and the effect of overexpression of complexin II. A,
example traces from a control (untransfected) cell and a cell
transfected to express complexin II (CPXII). B,
values for the number of spikes per cell following stimulation shown as
mean ± S.E. (n = 38 for controls,
n = 28 for complexin II-expressing cells).
C, values for charge (area) per spike shown as mean ± S.E. (n = 465 spikes for controls, n = 164 for complexin II-expressing cells). Cont,
control.

View larger version (13K):
[in a new window]
Fig. 3.
Amperometric recording of evoked exocytosis
and the effect of expression of complexin II(R59H). A,
example traces from a control (untransfected) cell and a cell
transfected to express complexin II(R59H). B and
C, values for the mean number of spikes per cell
(n = 33 for controls, n = 30 for
complexin II(R59H)-expressing cells) and mean values of charge per
spike (n = 681 spikes for controls, n = 533 spikes for complexin(R59H)-expressing cells). Cont,
control; CPXII, complexin II; n.s., not
significant.
The characteristics of the amperometric spikes in chromaffin cells
overexpressing complexin II or the R59H mutant were examined in more
detail. Overexpression of complexin II modified the shape of the
amperometric spikes resulting in significant decreases in height,
half-width, rise time to peak, and fall time (Fig. 4A). The effect of complexin
II on the frequency distribution of events is shown for half-width,
which reveals a shift to a population with narrower half-widths (Fig.
4B). In contrast, expression of complexin II(R59H) had no
effect on any of the spike parameters examined. Similar reductions in
half-width and rise time to those seen in complexin II-overexpressing
cells have been seen in chromaffin cells expressing the Munc18(R39C)
mutant that has reduced affinity for syntaxin (21) and also following
phorbol ester treatment (19). In both cases these modifications were
not accompanied by changes in spike height. As a consequence, spikes in
cells expressing Munc18(R39C) or treated with phorbol 12-myristate
13-acetate showed a significant increase in the rate of rise of
the spikes due to the decreased rise time (Fig. 4C). In
contrast, this parameter was unaffected by overexpression of complexin
II or the complexin II(R59H) mutant. These data suggest that complexin
II does not modulate the initial rate of the release events, but the
reduced half-width and charge suggest that it leads instead to
premature termination of the release event. The shape of the resulting
amperometric spikes demonstrates this point. The changes in
amperometric spikes (Fig. 4D) were distinct from those in
cells in which catecholamine was depleted as these showed both a
reduction in height and in the initial rate of rise of the spikes
(21).
|
| |
DISCUSSION |
|---|
|
|
|---|
Our data show that overexpression of complexin II in chromaffin
cells has two effects, an inhibition of the number of exocytotic events
and also changes in the kinetics of single vesicle release events
consistent with kiss-and-run exocytosis (22). In the crystal structure
of the complexin-SNARE complex, Arg-59 of complexin makes a crucial
interaction between complexin and the SNAREs (17). The reduced length
of the histidine side chain compared with arginine in the R59H mutant
we tested would prevent the formation of the salt bridge observed
between this residue and Asp-57 of synaptobrevin. Mutation of this
residue prevented the effects of complexin overexpression on both the
extent and the characteristics of the release events showing that these
effects were dependent on interaction of complexin II with the SNARE
complex. The interaction of complexin with Asp-57 is close to the
conserved zero layer residues of the SNARE complex. Mutation of the
zero layer residues does not, however, have any effect on the kinetics
of exocytosis (23, 24). The inhibitory effect of complexin II on spike
number is consistent with previous data showing reduced exocytosis in
transfected PC12 cells overexpressing complexin I or II (25) or
following acute microinjection of complexin II into Aplysia neurons
(26). This inhibitory effect was ascribed to competitive inhibition by
complexin of
-SNAP association with cis-SNARE complexes as it was
antagonized by co-injection of
-SNAP. The effect we observed here on
the kinetics of release events cannot be explained by competition with
-SNAP as we have shown that expression of a dominant negative
-SNAP mutant inhibited exocytosis in chromaffin cells but did not
modify spike kinetics (27). Similarly spike kinetics were not modified by a reduction in SNARE availability in cells transfected to express clostridial neurotoxins (19).
We and others have previously demonstrated that the kinetics of catecholamine release and extent of release can be modified at the level of a single vesicle (21, 27-31). We have interpreted these data as reflecting changes in the kinetics of fusion pore expansion and fusion pore open time (32). In support of the latter aspect we have found that spike half-width and quantal size are increased by disruption of dynamin function (33) indicating that the release time course is sensitive to disruption of dynamin-dependent vesicle retrieval. The effect of complexin II overexpression on spike parameters was to some extent similar to that seen in cells expressing the Munc18(R39C) mutant or after treatment with phorbol ester (19, 21) as in all cases spike half-width and quantal size were reduced. In contrast, however, the initial rate of spike rise was increased by Munc18(R39C) and phorbol ester but not by complexin II overexpression. These data suggest that complexin II was unusual in that it did not modify the rate of fusion pore expansion, but instead its major effect was to limit the time over which release occurred. This is consistent with complexin inducing earlier fusion pore closure to give rise to kiss-and-run exocytosis. Such a specific effect on vesicle release events has not previously been described under any other conditions.
Biochemical analysis of complexin has been limited to examination of
its interaction with assembled cis-SNARE complexes (as would occur
within the same membrane) (6, 8, 9, 17). Membrane fusion is mediated by
trans-SNARE complexes that bridge two membranes. Various studies, for
example using clostridial neurotoxins, have indicated the existence in
cells of multiple trans-SNARE complexes assembled to differing extents
prior to exocytosis (34, 35). One possible role for complexins would be
to stabilize a trans-SNARE complex intermediate that would be able to
allow rapid fusion pore closure after exocytosis. The rapid binding
kinetics of complexins to assembled SNAREs suggests that this
interaction could occur during or following membrane fusion. This
suggested role for complexins in favoring kiss-and-run exocytosis could
be consistent with the phenotype of complexin I/II knockout mice that
show a loss of fast synchronous neurotransmission (15). This is
maintained by rapid recycling of a small preferentially released pool
of synaptic vesicles that is reused over a time course of 1-3 s (36).
It is possible, therefore, that kiss-and-run exocytosis induced by
complexins could be essential for the rapid internalization of vesicles
into the ready releasable pool. The deficit in complexin I/II knockout
mice can be overcome by elevating Ca2+ concentration (15)
that could activate other pathways for rapid vesicle retrieval. Other
functional aspects of complexin interaction with the SNARE complex
cannot be ruled out, however. The ability of complexins to regulate
both the extent of exocytosis and nature of vesicle recycling would
make it a likely target for mechanisms regulating synaptic plasticity.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Harvey McMahon (Medical Research Council Laboratory of Molecular Biology, Cambridge, UK) for the plasmid encoding complexin II and for complexin II antiserum and Dr. Gareth Evans (Department of Physiology, University of Liverpool, UK) for the gift of rat brain synaptosomes.
| |
FOOTNOTES |
|---|
* This work was supported by a grant from the Wellcome Trust (to R. D. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Supported by a Wellcome Trust prize studentship.
§ To whom correspondence should be addressed. Tel.: 44-151-794-5305; Fax: 44-151-794-5337; E-mail: burgoyne@liverpool.ac.uk.
Published, JBC Papers in Press, April 2, 2002, DOI 10.1074/jbc.C200166200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: SNARE, soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptors; SNAP, soluble N-ethylmaleimide-sensitive fusion attachment protein; EGFP, enhanced green fluorescent protein; PBS, phosphate-buffered saline; PIPES, 1,4-piperazinediethanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Sollner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318-324[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Jahn, R., and Sudhof, T. C. (1999) Annu. Rev. Biochem. 68, 863-911[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Chen, Y. A., and Scheller, R. H. (2001) Nat. Rev. Mol. Cell Biol. 2, 98-106[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Sutton, R. B., Fasshauer, D., Jahn, R., and Brunger, A. T. (1998) Nature 395, 347-353[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Weber, T., Zemelman, B. V., McNew, J. A., Westermann, B., Gmachl, M., Parlati, F., Sollner, T. H., and Rothman, J. E. (1998) Cell 92, 759-772[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | McMahon, H. T., Missler, M., Li, C., and Sudhof, T. C. (1995) Cell 83, 111-119[CrossRef][Medline] [Order article via Infotrieve] |
| 7. | Ishizuka, T., Saisu, H., Odani, S., and Abe, T. (1995) Biochem. Biophys. Res. Commun. 213, 1107-1114[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Pabst, S.,
Hazzard, J. W.,
Antonin, W.,
Sudhof, T. C.,
Jahn, R.,
Rizo, J.,
and Fasshauer, D.
(2000)
J. Biol. Chem.
275,
19808-19818 |
| 9. |
Pabst, S.,
Margittai, M.,
Vainus, D.,
Langen, R.,
Jahn, R.,
and Fasshauer, D.
(2002)
J. Biol. Chem.
277,
7838-7848 |
| 10. | Burgoyne, R. D., and Morgan, A. (1995) Trends Neurosci. 18, 191-196[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Sabatini, B. L., and Regehr, W. G. (1996) Nature 384, 170-172[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Lindau, M., and Almers, W. (1995) Curr. Opin. Cell Biol. 7, 509-517[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Harata, N., Pyle, J. L., Aravanis, A. M., Mozhayeva, M., Kavali, E. T., and Tsien, R. W. (2001) Trends Neurosci. 24, 637-643[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Takahashi, S.-i., Ujihara, H., Huang, G.-Z., Yagyu, K.-i., Sanbo, M., Kaba, H., and Yagi, T. (1999) Eur. J. Neurosci. 11, 2359-2366[CrossRef][Medline] [Order article via Infotrieve] |
| 15. | Reim, K., Mansour, M., Varoqueaux, F., McMahon, H. T., Sudhof, T. C., Brose, N., and Rosenmund, C. (2001) Cell 104, 71-81[CrossRef][Medline] [Order article via Infotrieve] |
| 16. | Tokumaru, H., Umayahara, K., Pellegrini, L. L., Ishizuka, T., Saisu, H., Betz, H., Augustine, G. J., and Abe, T. (2001) Cell 104, 421-432[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Chen, X., Tomchick, D. R., Kovrigin, E., Arac, D., Machius, M., Sudhof, T. C., and Rizo, J. (2002) Neuron 33, 397-409[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Burgoyne, R. D. (1992) in Neuromethods: Intracellular Messengers (Boulton, A. , Baker, G. , and Taylor, C., eds), Vol. 20 , pp. 433-470, Humana Press Inc., Totowa, NJ |
| 19. | Graham, M. E., Fisher, R. J., and Burgoyne, R. D. (2000) Biochimie (Paris) 82, 469-479[Medline] [Order article via Infotrieve] |
| 20. |
Schroeder, T. J.,
Borges, R.,
Finnegan, J. M.,
Pihel, J.,
Amatore, C.,
and Wightman, R. M.
(1996)
Biophys. J.
70,
1061-1068 |
| 21. |
Fisher, R. J.,
Pevsner, J.,
and Burgoyne, R. D.
(2001)
Science
291,
875-878 |
| 22. | Fesce, R., Grohovaz, F., Valtorta, F., and Meldolesi, J. (1994) Trends Cell Biol. 4, 1-4[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Graham, M. E.,
Washbourne, P.,
Wilson, M. C.,
and Burgoyne, R. D.
(2001)
J. Cell Sci.
114,
4397-4405 |
| 24. |
Finley, M. F. A.,
Patel, S. M.,
Madison, D. V.,
and Scheller, R. H.
(2002)
J. Neurosci.
22,
1266-1272 |
| 25. | Itakura, M., Misawa, H., Sekiguchi, M., Takahashi, S., and Takahashi, M. (1999) Biochem. Biophys. Res. Commun. 265, 691-696[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Ono, S., Baux, G., Sekiguchi, M., Fossier, P., Morel, N. F., Nihonmatsu, I., Hirata, K., Awaji, T., Takahashi, S., and Takahashi, M. (1998) Eur. J. Neurosci. 10, 2143-2152[CrossRef][Medline] [Order article via Infotrieve] |
| 27. |
Graham, M. E.,
and Burgoyne, R. D.
(2000)
J. Neurosci.
20,
1281-1289 |
| 28. | Elhamdani, A., Martin, T. F. J., Kowalchyk, J. A., and Artalejo, C. R. (1999) J. Neurosci. 19, 7275-7383 |
| 29. |
Criado, M.,
Gil, A.,
Viniegra, S.,
and Gutierrez, L. M.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7256-7261 |
| 30. |
Machado, J. D.,
Morales, A.,
Gomez, J. F.,
and Borges, R.
(2001)
Mol. Pharmacol.
60,
514-520 |
| 31. |
Wang, C.-T.,
Grishanin, R.,
Earles, C. A.,
Chang, P. Y.,
Martin, T. F. J.,
Chapman, E. R.,
and Jackson, M. B.
(2001)
Science
294,
1111-1115 |
| 32. | Burgoyne, R. D., and Barclay, J. W. (2002) Trends Neurosci. 26, 176-178 |
| 33. | Graham, M. E., O'Callaghan, D. W., McMahon, H. T., and Burgoyne, R. D. (2002) Proc. Natl. Acad. Sci. U. S. A., in press |
| 34. | Xu, T., Rammner, B., Margittai, M., Artalejo, A. R., Neher, E., and Jahn, R. (1999) Cell 99, 713-722[CrossRef][Medline] [Order article via Infotrieve] |
| 35. | Hua, S.-H., and Charlton, M. P. (1999) Nat. Neurosci. 2, 1078-1083[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Pyle, J. L., Kavalali, E. T., Piedras-Renteria, E. S., and Tsien, R. W. (2000) Neuron 28, 221-231[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
M. Xue, A. Stradomska, H. Chen, N. Brose, W. Zhang, C. Rosenmund, and K. Reim Complexins facilitate neurotransmitter release at excitatory and inhibitory synapses in mammalian central nervous system PNAS, June 3, 2008; 105(22): 7875 - 7880. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang and M. B. Jackson Temperature Dependence of Fusion Kinetics and Fusion Pores in Ca2+-triggered Exocytosis from PC12 Cells J. Gen. Physiol., January 28, 2008; 131(2): 117 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Vardjan, M. Stenovec, J. Jorgacevski, M. Kreft, and R. Zorec Elementary properties of spontaneous fusion of peptidergic vesicles: fusion pore gating J. Physiol., December 15, 2007; 585(3): 655 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, G. J. Augustine, and K. Weninger Kinetics of Complexin Binding to the SNARE Complex: Correcting Single Molecule FRET Measurements for Hidden Events Biophys. J., September 15, 2007; 93(6): 2178 - 2187. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Larina, P. Bhat, J. A. Pickett, B. S. Launikonis, A. Shah, W. A. Kruger, J. M. Edwardson, and P. Thorn Dynamic Regulation of the Large Exocytotic Fusion Pore in Pancreatic Acinar Cells Mol. Biol. Cell, September 1, 2007; 18(9): 3502 - 3511. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Garcia, A. M. Garcia-De-Diego, L. Gandia, R. Borges, and J. Garcia-Sancho Calcium signaling and exocytosis in adrenal chromaffin cells. Physiol Rev, October 1, 2006; 86(4): 1093 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Giraudo, W. S. Eng, T. J. Melia, and J. E. Rothman A Clamping Mechanism Involved in SNARE-Dependent Exocytosis Science, August 4, 2006; 313(5787): 676 - 680. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nolan, A. E. Cowan, D. E. Koppel, H. Jin, and E. Grote FUS1 Regulates the Opening and Expansion of Fusion Pores between Mating Yeast Mol. Biol. Cell, May 1, 2006; 17(5): 2439 - 2450. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Obermuller, A. Lindqvist, J. Karanauskaite, J. Galvanovskis, P. Rorsman, and S. Barg Selective nucleotide-release from dense-core granules in insulin-secreting cells J. Cell Sci., September 15, 2005; 118(18): 4271 - 4282. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. L. Constable, M. E. Graham, A. Morgan, and R. D. Burgoyne Amisyn Regulates Exocytosis and Fusion Pore Stability by Both Syntaxin-dependent and Syntaxin-independent Mechanisms J. Biol. Chem., September 9, 2005; 280(36): 31615 - 31623. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Glynn, C. J. Drew, K. Reim, N. Brose, and A. J. Morton Profound ataxia in complexin I knockout mice masks a complex phenotype that includes exploratory and habituation deficits Hum. Mol. Genet., August 15, 2005; 14(16): 2369 - 2385. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Graham, J. W. Barclay, and R. D. Burgoyne Syntaxin/Munc18 Interactions in the Late Events during Vesicle Fusion and Release in Exocytosis J. Biol. Chem., July 30, 2004; 279(31): 32751 - 32760. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abderrahmani, G. Niederhauser, V. Plaisance, M.-E. Roehrich, V. Lenain, T. Coppola, R. Regazzi, and G. Waeber Complexin I regulates glucose-induced secretion in pancreatic {beta}-cells J. Cell Sci., May 1, 2004; 117(11): 2239 - 2247. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rickman, D. A. Archer, F. A. Meunier, M. Craxton, M. Fukuda, R. D. Burgoyne, and B. Davletov Synaptotagmin Interaction with the Syntaxin/SNAP-25 Dimer Is Mediated by an Evolutionarily Conserved Motif and Is Sensitive to Inositol Hexakisphosphate J. Biol. Chem., March 26, 2004; 279(13): 12574 - 12579. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Edwardson, C.-T. Wang, B. Gong, A. Wyttenbach, J. Bai, M. B. Jackson, E. R. Chapman, and A. J. Morton Expression of Mutant Huntingtin Blocks Exocytosis in PC12 Cells by Depletion of Complexin II J. Biol. Chem., August 15, 2003; 278(33): 30849 - 30853. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Duman and J. G. Forte What is the role of SNARE proteins in membrane fusion? Am J Physiol Cell Physiol, August 1, 2003; 285(2): C237 - C249. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Redecker, M. R. Kreutz, J. Bockmann, E. D. Gundelfinger, and T. M. Boeckers Brain Synaptic Junctional Proteins at the Acrosome of Rat Testicular Germ Cells J. Histochem. Cytochem., June 1, 2003; 51(6): 809 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Burgoyne and A. Morgan Secretory Granule Exocytosis Physiol Rev, April 1, 2003; 83(2): 581 - 632. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||